BMXXY.US bioMérieux SA

Healthcare Diagnostics & Research USA Stocks
10.45 USD
Close of Nov 13, 2026
7.12 14.35
Market cap
USD 12.3B
P/E
23.2x
P/B
2.59x
ROE
9.7%
Dividend yield
1.07%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is BMXXY.US undervalued?

Graham number
Price10.45
Graham value6.39
Premium63.4%

BMXXY.US trades 63.4% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

bioMérieux SA fundamental analysis

No fundamental analysis for bioMérieux SA yet.

bioMérieux SA stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About bioMérieux SA

bioMérieux S.A. develops, manufactures, and markets in vitro diagnostic solutions for infectious diseases in France, Europe, Africa, the Middle East, North and South America, the Asia Pacific, and internationally. It operates through Clinical Applications and Industrial Applications segments. The company offers CHROMID RANGE, a chromogen culture media; air, surface, and water monitoring systems; BACT/ALERT VIRTUO, a blood sample culture system; BIOFIRE, a multiplex polymeras…

Full company profile